Cargando…
Retraction Note: CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy
Autor principal: | Rabie, Amgad M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9440450/ https://www.ncbi.nlm.nih.gov/pubmed/36057028 http://dx.doi.org/10.1007/s11030-022-10521-6 |
Ejemplares similares
-
CoViTris2020 and ChloViD2020: a striking new hope in COVID-19 therapy
por: Rabie, Amgad M.
Publicado: (2021) -
Retraction Note to: Discovery of (E)-N-(4-cyanobenzylidene)-6-fluoro-3-hydroxypyrazine-2-carboxamide (cyanorona-20): the first potent and specific anti-COVID-19 drug
por: Rabie, Amgad M.
Publicado: (2022) -
Retraction Note: Vibrio parahaemolyticus RhsP represents a widespread group of pro-effectors for type VI secretion systems
por: Jiang, Nan, et al.
Publicado: (2019) -
VI 2020 FACT SHEET
por: Delieutraz, Celine
Publicado: (2019) -
Retraction notice to: Myosin VI contributes to malignant proliferation of human glioma cells
por: Xu, Rong, et al.
Publicado: (2017)